Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Biedermann

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|March 15, 2018
Development of a clinical prediction model for an international normalised ratio ≥ 4·5 in hospitalised patients using vitamin K antagonistsAlbert R Dreijer, Joseph S Biedermann, Jeroen Diepstraten, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2016
Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trialJ S Biedermann, S C Cannegieter, M Roest, et al.
European Heart Journal|February 3, 2018
Rosuvastatin use improves measures of coagulation in patients with venous thrombosisJoseph S Biedermann, Marieke J H A Kruip, Felix J van der Meer, et al.
Thrombosis and Haemostasis|April 14, 2017
Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists. A cohort studyJoseph S Biedermann, Willem M H Rademacher, Hendrika C A M Hazendonk, et al.
Thrombosis and Haemostasis|July 8, 2016
Control of anticoagulation with vitamin K antagonists: overestimation of median time in therapeutic range when assessed by linear interpolationA M H P van den Besselaar, Joseph S Biedermann, Felix J M van der Meer, et al.
BMC Geriatrics|March 27, 2019
Relative importance of four functional measures as predictors of 15-year mortality in the older Dutch populationElisabeth M W Eekhoff, Natasja M van Schoor, Joseph S Biedermann, et al.
European Journal of Clinical Investigation|April 24, 2018
Clinical effects of antiplatelet drugs and statins on D-dimer levelsSuzanne Schol-Gelok, Tom van der Hulle, Joseph S Biedermann, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2017
Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosisN van Rein, J S Biedermann, F J M van der Meer, et al.
Journal of Thrombosis and Haemostasis : JTH|December 25, 2021
Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trialCathrine Ramberg, Kristian Hindberg, Joseph S Biedermann, et al.
Thrombosis Research|July 13, 2015
Agreement between Coaguchek XS and STA-R Evolution (Hepato Quick) INR results depends on the level of INRJoseph S Biedermann, Frank W G Leebeek, Peter N Buhre, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|March 15, 2018
Development of a clinical prediction model for an international normalised ratio ≥ 4·5 in hospitalised patients using vitamin K antagonistsAlbert R Dreijer, Joseph S Biedermann, Jeroen Diepstraten, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2016
Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trialJ S Biedermann, S C Cannegieter, M Roest, et al.
European Heart Journal|February 3, 2018
Rosuvastatin use improves measures of coagulation in patients with venous thrombosisJoseph S Biedermann, Marieke J H A Kruip, Felix J van der Meer, et al.
Thrombosis and Haemostasis|April 14, 2017
Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists. A cohort studyJoseph S Biedermann, Willem M H Rademacher, Hendrika C A M Hazendonk, et al.
Thrombosis and Haemostasis|July 8, 2016
Control of anticoagulation with vitamin K antagonists: overestimation of median time in therapeutic range when assessed by linear interpolationA M H P van den Besselaar, Joseph S Biedermann, Felix J M van der Meer, et al.
BMC Geriatrics|March 27, 2019
Relative importance of four functional measures as predictors of 15-year mortality in the older Dutch populationElisabeth M W Eekhoff, Natasja M van Schoor, Joseph S Biedermann, et al.
European Journal of Clinical Investigation|April 24, 2018
Clinical effects of antiplatelet drugs and statins on D-dimer levelsSuzanne Schol-Gelok, Tom van der Hulle, Joseph S Biedermann, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2017
Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosisN van Rein, J S Biedermann, F J M van der Meer, et al.
Journal of Thrombosis and Haemostasis : JTH|December 25, 2021
Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trialCathrine Ramberg, Kristian Hindberg, Joseph S Biedermann, et al.
Thrombosis Research|July 13, 2015
Agreement between Coaguchek XS and STA-R Evolution (Hepato Quick) INR results depends on the level of INRJoseph S Biedermann, Frank W G Leebeek, Peter N Buhre, et al.
Pageof 3